Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

VION Biosciences Acquires CTL

Summary by Citybiz
VION Biosciences, a life sciences company building differentiated capabilities across research, diagnostics, and drug development workflows, today announced the closing of its acquisition of Cellular Technology Limited, a provider of functional immune monitoring analyzers, software, consumables, and services. This strategic acquisition strengthens VION’s goal to support its customers at a critical measurement layer in immune medicine: the abilit…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

citybizcitybiz

VION Biosciences Acquires CTL

VION Biosciences, a life sciences company building differentiated capabilities across research, diagnostics, and drug development workflows, today announced the closing of its acquisition of Cellular Technology Limited, a provider of functional immune monitoring analyzers, software, consumables, and services. This strategic acquisition strengthens VION’s goal to support its customers at a critical measurement layer in immune medicine: the abilit…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

citybiz broke the news in on Thursday, April 9, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Baltimore, MD icon

Baltimore, MD

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal